Amersham International (UK) and Molecular Dynamics (US) invest in Canada:
This article was originally published in Clinica
Amersham International (UK) and Molecular Dynamics (US) have concluded a $5 million joint investment and marketing agreement with Visible Genetics. The latter is a privately-held Canadian company producing DNA sequencers, microgels and other products for the research market. Amersham and Molecular Dynamics will market these products exclusively as an extension of the Vistra DNA range.